22
Backers in a recent round
22 added at least one new company in this market. The remainder participated only in companies they had already backed here.
Explore recently active backers ↗MARKET NOTES / 001CHINA / SHANGHAI / BIOPHARMA OUTSOURCING
LESS GUESSWORK. A BETTER RESEARCH LIST.Biopharma Outsourcing.
Biopharma Outsourcing.
Shanghai.
Map the capital.
Find your next conversation.
Who backs this market, where they enter, and how recently they have added a new company. A directory built around the questions founders actually ask.
Build your research shortlist ↘Companies are based in Shanghai · investors can be based anywhere
Dataset through 22 May 2026 · calculated 14 Sep 2026
01 / THE SHORTLIST LAB
Make the list work for your company.
12 backers based in Shanghai are shown by default. Compare up to three.
A CLOSER LOOK AT WHERE
Find investors in your preferred location.
Search a recorded city, country or neighbourhood among the backers of this market.
Five location searches per day. Results use recorded locations; some investors have city-level coverage only.
12 of 40 selected backers · Shanghai only
Shows investors whose recorded city is Shanghai. Unknown cities are excluded. Market charts cover all investor locations.
Theme filtering selects backers of companies carrying that theme tag. Entry-stage filtering selects backers with an entry at that stage; the two matches may be different companies. Row metrics describe their entire dated Biopharma Outsourcing history in Shanghai.
Your side-by-side comparison
Lead flags and later investments may be incompletely recorded. Repeat counts are not adjusted for time since entry.
| Compare | Investor / recorded location | Companies here | New in 24 months | Median total entry round | Companies backed again | Latest investment |
|---|---|---|---|---|---|---|
| Loading investors… | ||||||
No backers match these filters. Broaden the theme, location, entry stage or activity window.
02 / THE MARKET READActivity is a better starting point
Activity is a better starting point
than a long list of names.
Latest 24 months: after 22 May 2024 through 22 May 2026.
4
Distinct equity rounds
Across 3 companies, versus 16 rounds in the preceding 24 months. Each company round is counted once.
See the recent evidence ↗50%
Rounds at Angel, Pre-Seed or Seed
2 of 4 recent rounds. Compare your stage with its own financing range before sizing the ask.
Compare stage ranges ↗96%
Participations were first entries
22 first investor–company relationships out of 23 participations. The other 1 were later rounds together.
Find backers adding companies ↗Build a syndicate beyond the city.
Of 22 recently active backers, 4 have a recorded Shanghai location and 10 are based elsewhere. Location is missing for 8. Search by market experience first, then investigate the people and their remit.
Match the whole round to your plan.
Recent Seed rounds have a median size of $55M, across 2 disclosed amounts. That is total company financing. An individual investor’s cheque or available capital is not disclosed here.
04 / THE DEPTH MAP
One appearance, or a pattern?
101 of 122 backers with dated histories appear in just one company. Select a cell to explore the directory.
| Portfolio breadth here | 1 company | 2 companies | 3–5 | 6–10 | 11+ |
|---|---|---|---|---|---|
| Firms & institutions | |||||
| Individual angels |
Circle area increases with backer count. The shortlist includes backers with 2 or more companies in this market, plus other backers active in the latest 24 months. In the 1-company cell, only recently active backers are available to explore. The shortlist’s investor-location filter also applies; select all locations to broaden the results. 1 backers have only undated entries.
05 / ROUND DESIGN
Different stages. Different capital.
Recent equity rounds · 24-month window.
Amounts are in USD.
StageDistinct roundsMedian / middle half
Seed
2
$55M$53M–$58M2 disclosed · small sample
Series A
1
$5.4M$5.4M–$5.4M1 disclosed · small sample
Series B
1
$45M$45M–$45M1 disclosed · small sample
06 / FOLLOW THE EVIDENCE
The most recent recorded rounds.
Distinct company rounds.
Named backers are shown lead-first.
Provider of consulting services in the field of chemical research and development through artificial intelligence chemical synthesis
$45M total equity round1 named backer
Granite Asia
Biotechnology research company developing biological drugs
$60M total equity round11 named backers
Shunwei Capital · Delian Capital · Hankang Capital · Honghui Fund · Langmafeng Venture Capital · +6 more
CRO focused on providing data management services
$5.4M total equity round3 named backers
LingDu Capital · Jun Investment · Pingtianhu Industrial Investment
Biotechnology research company developing biological drugs
$50M total equity round8 named backers
Panacea Venture · Delian Capital · Everjoy Fortune · HLC · Lenovo · +3 more
Provider of consulting services in the field of chemical research and development through artificial intelligence chemical synthesis
$26M total equity round4 named backers
LYFE Capital · Qiming Venture Partners · MEGAROBO · Sinovation Ventures
Pharmaceutical company that develops and manufactures a range of pharmaceutical products, including steroids, hormone intermediates, and APIs
Undisclosed total equity round1 named backer
Orbimed
07 / READING THE ATLAS
What these patterns can tell you.
The market boundary
Recorded equity rounds for companies tagged Biopharma Outsourcing and located in Shanghai. Investor headquarters may be elsewhere. Company sector and location reflect the available company records, not necessarily the location or sector at the investment date.
The time boundary
Data coverage ends 22 May 2026. The latest market round is 08 Dec 2025. There are 3 undated participations, excluded from timing metrics. Activity after the cutoff is unknown.
The relationship boundary
“New” is the first dated relationship between a backer and a company in this market. “Backed again” requires a later dated round together. A first observed entry may follow an earlier unrecorded investment.
The financing boundary
Amounts describe entire equity rounds, not personal cheques, fund capacity or returns. Medians exclude missing and non-positive amounts; the middle half spans the 25th–75th percentiles. A recorded investment does not establish current availability.
Find the businesses
worth a closer look.
Search Shanghai Biopharma Outsourcing companies in Radar. Filter the company directory to explore the businesses behind your market and investor research.
Explore companies in Radar ↗A research dashboard.
Built for your company.
We build customized research dashboards for companies. Tell us which competitors, markets and questions matter to your team, and discuss a dashboard designed around your needs.
Discuss a custom dashboard ↗A customized service from Fliar. Contact us to discuss your requirements.Turn your questions
into deeper research.
Use Fliar Prism to research a company, market or topic, with reports and insights drawn from its research dataset.
Explore Fliar Prism ↗Start with the company or question you want to understand.Calculated 14 Sep 2026 · 40 investor histories to explore